This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Clexio Biosciences Ltd.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Johanna Schumann
Introduction
Johanna Schumann is a notable inventor based in Jerusalem, Israel. She has made significant contributions to the field of medicine, particularly in the treatment of major depressive disorder. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Johanna's latest patents focus on a dosage regime with esketamine for treating major depressive disorder. The first patent provides a method for safe and efficacious administration of esketamine. The second patent also discloses methods for the safe and effective use of esketamine in treatment protocols. These innovations are crucial in enhancing patient care and improving treatment outcomes.
Career Highlights
Johanna Schumann is currently associated with Clexio Biosciences Ltd., where she continues to develop her groundbreaking ideas. Her work at the company reflects her commitment to advancing medical science and improving mental health treatment options.
Collaborations
Johanna collaborates with Dorit Mimrod, who is also a key figure in their research endeavors. Together, they are working towards innovative solutions in the field of mental health.
Conclusion
Johanna Schumann's contributions to the field of medicine through her patents and collaborations highlight her role as an influential inventor. Her work is essential in the ongoing quest for effective treatments for major depressive disorder.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile